Honesti Basyir is putting Kimia Farma on a growth path.
PT Kimia Farma is the country’s biggest state-owned pharmaceutical company. In 2017, it re-corded annual revenue growth of 5.4% to Rp 6.1 trillion, in line with the 5% national growth of the sector. In profits, however, the company is on a roll. Last year, net profit jumped 22% to Rp 332 billion. “Improvement of production operations had a big impact on efficiency. By focusing on our production system, we were able to maintain our cost of goods,” says Kimia Farma President Director Honesti Basyir. For example, Kimia Farma is now buying its raw material in bulk, with long-term contracts, to get them at lower prices.
Despite the good results, Honesti wants to aim higher. He targets Kimia Farma to have revenue growth of at least 10%, and become one of the top three largest drugmakers in the country (it now ranks sixth, by revenue). To reach that goal, Honesti, who joined the company last year, aims to aggressively expand the firm, in part through M&A. He has allocated Rp 3.5 trillion for capital expenditure, some Rp 2.2 trillion of which will be used to acquire other companies in injection drugs, medical devices, hospitals and cosmetics.
This story is from the May 2018 edition of Forbes Indonesia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the May 2018 edition of Forbes Indonesia.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
BACK ON TRACK
Collective wealth gets a 21% boost to a record $162 billion amid an economic uptick.
Championing Locals
The wave of social commerce is enabling inclusive digital economies beyond urban areas.
Boys in the Bubble
Startups are supposed to specialize, but OPENSEA’s founders thrived by building a wide-open market for creating and trading all manner of NFTs, whether art, music or gaming. Now that they’re centimillionaires and poised to become billionaires, they have other worries: competitors, fraudsters and the next crypto crash.
Enduring Relations
The implementation of IA-CEPA amid the pandemic signifies the Indonesia-Australia’s commitment to recover and counter future challenges together.
Sweet Success
Steven Erwin envisions Unifam to become a major global player in the confectionery and F&B industry.
Marathon Man
Across America, scores of municipal pension funds remain scandalously underfunded. But not the pension fund of Tampa’s police and firemen, thanks in large part to JAY BOWEN, whose no-frills approach to stock picking has protected and served them for more than 45 years.
Gold Rallies on Inflation Fears
During September the price of gold rallied to $1,868 per ounce following the release of figures on US inflation by the Bureau of Labor Statistics which indicated that, as of September, CPI inflation had rocketed to 6.2%, above the 5.8% which economists had been predicting.
Set Off to A New Start
Bank Aladin has two main ingredients for success: establish trust and offer better customer experiences.
The Daily Intake
YOUVIT plans to invest further into marketing and grow into one of the leading vitamin brands in Indonesia.
THE CROESUS OF CRYPTO
FTX COFOUNDER SAM BANKMAN-FRIED BUILT A $22.5 BILLION FORTUNE BEFORE HIS 30TH BIRTHDAY BY PROFITING OFF THE CRYPTOCURRENCY FRENZY—BUT HE’S NOT A TRUE BELIEVER. HE JUST WANTS HIS WEALTH TO SURVIVE LONG ENOUGH TO GIVE IT ALL AWAY.
